4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-26-000002
Director sold 15,960 shares at an average $45.22 ($721,635)
- Director acquired 15,960 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Quart Barry D Director | 2026-02-02 | Option exercise 10b5-1 | +830 | $15.47 | $12,840 | 13,376 | D |
| Quart Barry D Director | 2026-02-02 | Sale 10b5-1 | −830 | $45.00 | $37,350 | 12,546 | D |
| Quart Barry D Director | 2026-02-03 | Option exercise 10b5-1 | +12,528 | $15.47 | $193,808 | 25,074 | D |
| Quart Barry D Director | 2026-02-03 | Sale 10b5-1 | −12,528 | $45.27 | $567,143 | 12,546 | D |
| Quart Barry D Director | 2026-02-04 | Option exercise 10b5-1 | +2,602 | $15.47 | $40,253 | 15,148 | D |
| Quart Barry D Director | 2026-02-04 | Sale 10b5-1 | −2,602 | $45.02 | $117,142 | 12,546 | D |
| Derivatives | |||||||
| Quart Barry D Director | 2026-02-02 | Option exercise · Share Option 10b5-1 | −830 | 17,930 | D | ||
| Quart Barry D Director | 2026-02-03 | Option exercise · Share Option 10b5-1 | −12,528 | 5,402 | D | ||
| Quart Barry D Director | 2026-02-04 | Option exercise · Share Option 10b5-1 | −2,602 | 2,800 | D | ||
| Open-market sales · 15,960 sh · avg $45.22 · $721,635 | |||||||
Loading xslF345X05/form4-02042026_110219.xml…